Evicenter
Verzenio (abemaciclib) in HR-positive HER2-negative early breast cancer
Manufacturer
Lilly USA, LLC
Prescribing information
Verzenio (opens in a new tab)
Questions
27
Last updated

All questions

Indication: Verzenio (abemaciclib) in HR-positive HER2-negative early breast cancer

3 questions · 2 sources

Indication

What is Verzenio approved for in early breast cancer?

Eligibility

What does high risk of recurrence mean for Verzenio in early breast cancer?

Is Verzenio approved for monarchE Cohort 2 patients selected by Ki-67 score?